Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H12 |
| Molecular Weight | 180.2451 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1=CC=C(C=C1)\C=C\C2=CC=CC=C2
InChI
InChIKey=PJANXHGTPQOBST-VAWYXSNFSA-N
InChI=1S/C14H12/c1-3-7-13(8-4-1)11-12-14-9-5-2-6-10-14/h1-12H/b12-11+
| Molecular Formula | C14H12 |
| Molecular Weight | 180.2451 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006-11 |
|
| 3,4',5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling. | 2004-08 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:18:28 GMT 2025
by
admin
on
Mon Mar 31 21:18:28 GMT 2025
|
| Record UNII |
3FA7NW80A0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
638088
Created by
admin on Mon Mar 31 21:18:28 GMT 2025 , Edited by admin on Mon Mar 31 21:18:28 GMT 2025
|
PRIMARY | |||
|
203-098-5
Created by
admin on Mon Mar 31 21:18:28 GMT 2025 , Edited by admin on Mon Mar 31 21:18:28 GMT 2025
|
PRIMARY | |||
|
5020
Created by
admin on Mon Mar 31 21:18:28 GMT 2025 , Edited by admin on Mon Mar 31 21:18:28 GMT 2025
|
PRIMARY | |||
|
(E)-Stilbene
Created by
admin on Mon Mar 31 21:18:28 GMT 2025 , Edited by admin on Mon Mar 31 21:18:28 GMT 2025
|
PRIMARY | |||
|
3FA7NW80A0
Created by
admin on Mon Mar 31 21:18:28 GMT 2025 , Edited by admin on Mon Mar 31 21:18:28 GMT 2025
|
PRIMARY | |||
|
2069
Created by
admin on Mon Mar 31 21:18:28 GMT 2025 , Edited by admin on Mon Mar 31 21:18:28 GMT 2025
|
PRIMARY | |||
|
m10216
Created by
admin on Mon Mar 31 21:18:28 GMT 2025 , Edited by admin on Mon Mar 31 21:18:28 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID4026050
Created by
admin on Mon Mar 31 21:18:28 GMT 2025 , Edited by admin on Mon Mar 31 21:18:28 GMT 2025
|
PRIMARY | |||
|
36007
Created by
admin on Mon Mar 31 21:18:28 GMT 2025 , Edited by admin on Mon Mar 31 21:18:28 GMT 2025
|
PRIMARY | |||
|
103-30-0
Created by
admin on Mon Mar 31 21:18:28 GMT 2025 , Edited by admin on Mon Mar 31 21:18:28 GMT 2025
|
PRIMARY |